Envista Holdings Corporation
US ˙ NYSE ˙ US29415F1049

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Kieran Gallahue. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Kieran Gallahue har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:NVST / Envista Holdings Corporation Director 44.680
US:EW / Edwards Lifesciences Corporation Director 4.682
US:XENT / Intersect ENT Inc Director 0
US:ARNA / Arena Pharmaceuticals Inc Director 0
US:CFN / CareFusion Corporation Chairman and CEO, Director 0
US:VOLC / Volcano Corp Director 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Kieran Gallahue. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb NVST / Envista Holdings Corporation – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i NVST / Envista Holdings Corporation. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

NVST / Envista Holdings Corporation Insider Trades
Insidersalg NVST / Envista Holdings Corporation – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i NVST / Envista Holdings Corporation. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

NVST / Envista Holdings Corporation Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Kieran Gallahue som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-06-12 2025-06-10 4 NVST Envista Holdings Corp
Common Stock
A - Award 10.450 44.680 30,53
2025-05-09 2025-05-09 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 1.154 4.682 32,71
2025-05-09 2025-05-09 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 3.528 3.528
2024-05-23 2024-05-21 4 NVST Envista Holdings Corp
Common Stock
A - Award 10.085 34.230 41,77
2024-05-09 2024-05-08 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 999 4.054 32,70
2024-05-09 2024-05-08 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 3.055 3.055
2024-02-26 2024-02-23 4 EW Edwards Lifesciences Corp
Common Stock
S - Sale -3.058 67.219 -4,35 87,61 -267.911 5.889.057
2024-02-26 2024-02-23 4 EW Edwards Lifesciences Corp
Common Stock
G - Gift 7.056 70.277 11,16
2024-02-26 2024-02-23 4 EW Edwards Lifesciences Corp
Common Stock
G - Gift -7.056 3.701 -65,59
2024-02-26 2024-02-23 4 EW Edwards Lifesciences Corp
Common Stock
M - Exercise 7.056 10.757 190,65 36,86 260.107 396.539
2023-05-25 2023-05-23 4 NVST Envista Holdings Corp
Common Stock
A - Award 5.425 24.145 28,98
2023-05-15 2023-05-12 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 898 3.701 32,04
2023-05-15 2023-05-12 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 2.803 2.803
2022-05-31 2022-05-24 4 NVST Envista Holdings Corp
Common Stock
A - Award 4.435 18.720 31,05
2022-05-16 2022-05-13 4 XENT Intersect ENT, Inc.
Stock Options (Right to buy)
U - Other -13.248 0 -100,00 28,25 -374.256
2022-05-16 2022-05-13 4 XENT Intersect ENT, Inc.
Stock Options (Right to buy)
U - Other -25.000 0 -100,00 28,25 -706.250
2022-05-16 2022-05-13 4 XENT Intersect ENT, Inc.
Stock Options (Right to buy)
U - Other -6.035 0 -100,00 28,25 -170.489
2022-05-16 2022-05-13 4 XENT Intersect ENT, Inc.
Stock Options (Right to buy)
U - Other -3.473 0 -100,00 28,25 -98.112
2022-05-16 2022-05-13 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
U - Other -9.666 0 -100,00 28,25 -273.064
2022-05-16 2022-05-13 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
U - Other -12.500 0 -100,00 28,25 -353.125
2022-05-16 2022-05-13 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
U - Other -5.734 0 -100,00 28,25 -161.986
2022-05-16 2022-05-13 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
U - Other -82.387 0 -100,00 28,25 -2.327.433
2022-05-16 2022-05-13 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
U - Other -3.390 0 -100,00 28,25 -95.768
2022-05-16 2022-05-13 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
U - Other -120.064 0 -100,00 28,25 -3.391.808
2022-05-16 2022-05-13 4 XENT Intersect ENT, Inc.
Common Stock
U - Other -29.262 0 -100,00 28,25 -826.652
2022-05-16 2022-05-13 4 XENT Intersect ENT, Inc.
Common Stock
U - Other -5.011 0 -100,00 28,25 -141.561
2022-05-16 2022-05-13 4 XENT Intersect ENT, Inc.
Common Stock
U - Other -3.239 5.011 -39,26 28,25 -91.502 141.561
2022-05-10 2022-05-04 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 737 3.037 32,04
2022-05-10 2022-05-04 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 2.300 2.300
2022-03-11 2022-03-11 4 ARNA ARENA PHARMACEUTICALS INC
Stock Option (right to buy)
D - Sale to Issuer -7.202 0 -100,00
2022-03-11 2022-03-11 4 ARNA ARENA PHARMACEUTICALS INC
Stock Option (right to buy)
D - Sale to Issuer -5.000 0 -100,00
2022-03-11 2022-03-11 4 ARNA ARENA PHARMACEUTICALS INC
Stock Option (right to buy)
D - Sale to Issuer -5.000 0 -100,00
2022-03-11 2022-03-11 4 ARNA ARENA PHARMACEUTICALS INC
Stock Option (right to buy)
D - Sale to Issuer -4.583 0 -100,00
2022-03-11 2022-03-11 4 ARNA ARENA PHARMACEUTICALS INC
Stock Option (right to buy)
D - Sale to Issuer -2.500 0 -100,00
2022-03-11 2022-03-11 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
J - Other -8.167 0 -100,00
2022-03-11 2022-03-11 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
J - Other -1.116 8.167 -12,02
2022-03-11 2022-03-11 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
J - Other -3.628 0 -100,00
2022-02-08 2022-02-08 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
M - Exercise -32.256 0 -100,00
2022-02-08 2022-02-08 4 EW Edwards Lifesciences Corp
Common Stock
S - Sale -32.256 3.433 -90,38 110,79 -3.573.510 380.328
2022-02-08 2022-02-08 4 EW Edwards Lifesciences Corp
Common Stock
M - Exercise 32.256 35.689 939,59 22,29 718.880 795.390
2021-06-15 2021-06-11 4 ARNA ARENA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 7.202 7.202
2021-06-15 2021-06-11 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
A - Award 3.067 9.283 49,34
2021-06-07 2021-06-03 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
A - Award 5.734 5.734
2021-06-07 2021-06-03 4 XENT Intersect ENT, Inc.
Common Stock
A - Award 3.239 8.250 64,64
2021-05-27 2021-05-25 4 NVST Envista Holdings Corp
Common Stock
A - Award 4.020 14.285 39,16
2021-05-07 2021-05-07 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 818 3.433 31,28
2021-05-07 2021-05-07 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 2.615 2.615
2021-03-18 2021-03-16 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
A - Award 3.390 3.390
2021-02-16 2020-12-21 5 ARNA ARENA PHARMACEUTICALS INC
Common Stock
G - Gift -3.628 6.216 -36,85
2020-06-16 2020-06-12 4 ARNA ARENA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 5.000 5.000
2020-06-16 2020-06-12 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
A - Award 2.446 9.844 33,06
2020-06-08 2020-06-04 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
A - Award 9.666 9.666
2020-06-08 2020-06-04 4 XENT Intersect ENT, Inc.
Common Stock
A - Award 5.011 34.273 17,12
2020-05-29 2020-05-27 4 NVST Envista Holdings Corp
Restricted Stock Unit
A - Award 8.230 8.230
2020-05-11 2020-05-08 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 345 1.446 31,34
2020-05-11 2020-05-08 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 1.101 1.101
2020-05-11 2020-05-07 4 EW Edwards Lifesciences Corp
Common Stock
G - Gift 1.737 17.471 11,04
2020-05-11 2020-05-07 4 EW Edwards Lifesciences Corp
Common Stock
G - Gift -1.737 0 -100,00
2019-12-20 2019-12-18 4 NVST Envista Holdings Corp
Common Stock
A - Award 2.035 2.035
2019-10-02 2019-09-30 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
A - Award 82.387 82.387
2019-10-02 2019-09-30 4 XENT Intersect ENT, Inc.
Common Stock
A - Award 17.202 29.262 142,64
2019-06-17 2019-06-13 4 ARNA ARENA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 5.000 5.000
2019-06-17 2019-06-13 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
A - Award 2.654 7.398 55,94
2019-05-13 2019-05-09 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 414 1.737 31,29
2019-05-13 2019-05-09 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 1.323 1.323
2019-05-08 2019-05-07 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
A - Award 180.096 180.096
2018-07-10 2018-07-06 4 ARNA ARENA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 4.583 4.583
2018-07-10 2018-07-06 4 ARNA ARENA PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 2.500 2.500
2018-07-10 2018-07-06 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
A - Award 3.070 4.744 183,39
2018-07-10 2018-07-06 4 ARNA ARENA PHARMACEUTICALS INC
Common Stock
A - Award 1.674 1.674
2018-06-07 2018-06-05 4 XENT Intersect ENT, Inc.
Stock Options (Right to buy)
A - Award 3.473 3.473
2018-06-07 2018-06-05 4 XENT Intersect ENT, Inc.
Common Stock
A - Award 1.514 12.060 14,36
2018-05-22 2018-05-18 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 479 2.134 28,94
2018-05-22 2018-05-18 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 1.655 1.655
2018-05-22 2018-05-12 4 EW Edwards Lifesciences Corp
Common Stock
G - Gift 2.034 13.600 17,59
2018-05-22 2018-05-12 4 EW Edwards Lifesciences Corp
Common Stock
G - Gift -2.034 0 -100,00
2017-06-05 2017-06-01 4 XENT Intersect ENT, Inc.
Stock Options (Right to buy)
A - Award 6.035 6.035
2017-06-05 2017-06-01 4 XENT Intersect ENT, Inc.
Common Stock
A - Award 2.546 10.546 31,82
2017-05-15 2017-05-12 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
A - Award 2.352 2.352
2017-05-15 2017-05-12 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 2.034 2.034
2017-02-06 2017-02-03 4 EW Edwards Lifesciences Corp
Common Stock
P - Purchase 3.000 9.042 49,65 90,10 270.300 814.684
2017-01-20 2017-01-18 4 XENT Intersect ENT, Inc.
Stock Options (Right to buy)
A - Award 13.248 13.248
2016-12-01 2016-11-29 4 EW Edwards Lifesciences Corp
Common Stock
P - Purchase 3.000 6.042 98,62 84,63 253.900 511.355
2016-06-06 2016-06-02 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
A - Award 12.500 12.500
2016-05-17 2016-05-16 4 XENT Intersect ENT, Inc.
Common Stock
P - Purchase 8.000 8.000 12,64 101.111 101.111
2016-05-17 2016-05-13 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 583 5.566 11,70
2016-05-17 2016-05-13 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 1.941 4.983 63,81
2015-05-19 2015-05-15 4 EW Edwards Lifesciences Corp
Common Stock
A - Award 1.521 1.521
2015-04-10 2015-04-08 4 XENT Intersect ENT, Inc.
Stock Option (right to buy)
A - Award 25.000 25.000
2015-03-19 2015-03-17 4 CFN CAREFUSION Corp
Options (right to buy)
D - Sale to Issuer -350.997 0 -100,00
2015-03-19 2015-03-17 4 CFN CAREFUSION Corp
Options (right to buy)
D - Sale to Issuer -266.430 0 -100,00
2015-03-19 2015-03-17 4 CFN CAREFUSION Corp
Options (right to buy)
D - Sale to Issuer -159.464 0 -100,00
2015-03-19 2015-03-17 4 CFN CAREFUSION Corp
Restricted Stock Units
D - Sale to Issuer -44.348 0 -100,00
2015-03-19 2015-03-17 4 CFN CAREFUSION Corp
Restricted Stock Units
D - Sale to Issuer -35.942 0 -100,00
2015-03-19 2015-03-17 4 CFN CAREFUSION Corp
Restricted Stock Units
D - Sale to Issuer -23.330 0 -100,00
2015-03-19 2015-03-17 4 CFN CAREFUSION Corp
Performance Stock Units
D - Sale to Issuer -79.131 0 -100,00
2015-03-19 2015-03-17 4 CFN CAREFUSION Corp
Performance Stock Units
D - Sale to Issuer -107.824 0 -100,00
2015-03-19 2015-03-17 4 CFN CAREFUSION Corp
Performance Stock Units
D - Sale to Issuer -139.978 0 -100,00
2015-03-19 2015-03-17 4 CFN CAREFUSION Corp
Performance Stock Units
A - Award 79.131 79.131
2015-03-19 2015-03-17 4 CFN CAREFUSION Corp
Performance Stock Units
A - Award 107.824 107.824
2015-03-19 2015-03-17 4 CFN CAREFUSION Corp
Performance Stock Units
A - Award 139.978 139.978
2015-03-19 2015-03-17 4 CFN CAREFUSION Corp
Common Stock
D - Sale to Issuer -740.251 0 -100,00
2015-03-13 2015-03-11 4 CFN CAREFUSION Corp
Stock options (right to buy)
M - Exercise -133.215 266.430 -33,33
2015-03-13 2015-03-11 4 CFN CAREFUSION Corp
Stock options (right to buy)
M - Exercise -318.928 159.464 -66,67
2015-03-13 2015-03-11 4 CFN CAREFUSION Corp
Stock options (right to buy)
M - Exercise -503.306 0 -100,00
2015-03-13 2015-03-11 4 CFN CAREFUSION Corp
Stock options (right to buy)
M - Exercise -533.110 0 -100,00
2015-03-13 2015-03-11 4 CFN CAREFUSION Corp
Common Stock
F - Taxes -1.103.089 740.251 -59,84 59,73 -65.887.506 44.215.192
2015-03-13 2015-03-11 4 CFN CAREFUSION Corp
Common Stock
M - Exercise 133.215 1.843.340 7,79 36,17 4.818.387 66.673.608
2015-03-13 2015-03-11 4 CFN CAREFUSION Corp
Common Stock
M - Exercise 318.928 1.710.125 22,92 26,79 8.544.081 45.814.249
2015-03-13 2015-03-11 4 CFN CAREFUSION Corp
Common Stock
M - Exercise 503.306 1.391.197 56,69 25,56 12.864.501 35.558.995
2015-03-13 2015-03-11 4 CFN CAREFUSION Corp
Common Stock
M - Exercise 533.110 887.891 150,26 27,84 14.841.782 24.718.885
2015-02-23 2015-02-19 4 EW Edwards Lifesciences Corp
Director Stock Option (Right to Acquire)
A - Award 5.376 5.376
2015-02-19 2015-02-17 4 VOLC Volcano Corp
Restricted Stock Units
D - Sale to Issuer -3.575 0 -100,00 18,00 -64.350
2015-02-19 2015-02-17 4 VOLC Volcano Corp
Non-Qualified Stock Option (Right to Buy)
D - Sale to Issuer -10.049 0 -100,00 0,52 -5.225
2015-02-19 2015-02-17 4 VOLC Volcano Corp
Non-Qualified Stock Option (Right to Buy)
D - Sale to Issuer -10.840 0 -100,00 1,16 -12.574
2015-02-19 2015-02-17 4 VOLC Volcano Corp
Non-Qualified Stock Option (Right to Buy)
D - Sale to Issuer -12.000 0 -100,00 3,09 -37.080
2015-02-19 2015-02-17 4 VOLC Volcano Corp
Non-Qualified Stock Option (Right to Buy)
D - Sale to Issuer -8.000 0 -100,00 4,84 -38.720
2015-02-19 2015-02-17 4 VOLC Volcano Corp
Common Stock
D - Sale to Issuer -9.738 0 -100,00 18,00 -175.284
2014-12-19 2014-12-09 4 CFN CAREFUSION Corp
Common Stock
G - Gift -4.250 354.781 -1,18
2014-08-19 2014-08-15 4 CFN CAREFUSION Corp
Options (right to buy)
A - Award 350.997 350.997
2014-08-19 2014-08-15 4 CFN CAREFUSION Corp
Restricted Stock Units
A - Award 44.348 44.348
2014-08-19 2014-08-15 4 CFN CAREFUSION Corp
Restricted Stock Units
M - Exercise -17.970 35.942 -33,33
2014-08-19 2014-08-15 4 CFN CAREFUSION Corp
Restricted Stock Units
M - Exercise -23.330 23.330 -50,00
2014-08-19 2014-08-15 4 CFN CAREFUSION Corp
Restricted Stock Units
M - Exercise -24.453 0 -100,00
2014-08-19 2014-08-15 4 CFN CAREFUSION Corp
Common Stock
F - Taxes -34.311 359.031 -8,72 44,04 -1.511.056 15.811.725
2014-08-19 2014-08-15 4 CFN CAREFUSION Corp
Common Stock
M - Exercise 65.753 393.342 20,07
2014-08-07 2014-08-05 4 CFN CAREFUSION Corp
Common Stock
F - Taxes -24.481 327.589 -6,95 42,90 -1.050.235 14.053.568
2014-08-07 2014-08-05 4 CFN CAREFUSION Corp
Common Stock
A - Award 46.948 352.070 15,39
2014-06-05 2014-06-03 4 VOLC Volcano Corp
Restricted Stock Units
A - Award 3.575 3.575
2014-06-05 2014-06-03 4 VOLC Volcano Corp
Non-Qualified Stock Option (Right to Buy)
A - Award 10.049 10.049 17,48 175.657 175.657
2014-05-20 2014-05-20 4 CFN CAREFUSION Corp
Stock Options (right to buy)
M - Exercise -100.000 533.110 -15,80
2014-05-20 2014-05-20 4 CFN CAREFUSION Corp
Common Stock
S - Sale -100.000 305.122 -24,68 42,98 -4.298.000 13.114.144
2014-05-20 2014-05-20 4 CFN CAREFUSION Corp
Common Stock
M - Exercise 100.000 405.122 32,77 27,84 2.784.000 11.278.596
2014-05-19 2014-05-15 4 VOLC Volcano Corp
Restricted Stock Units
M - Exercise -3.711 0 -100,00
2014-05-19 2014-05-15 4 VOLC Volcano Corp
Common Stock
M - Exercise 3.711 9.738 61,57
2014-02-18 2014-02-15 4 CFN CAREFUSION Corp
Performance Stock Units
M - Exercise -246.697 0 -100,00
2014-02-18 2014-02-15 4 CFN CAREFUSION Corp
Common Stock
F - Taxes -128.727 305.122 -29,67 40,95 -5.271.371 12.494.746
2014-02-18 2014-02-15 4 CFN CAREFUSION Corp
Common Stock
M - Exercise 246.697 433.849 131,82
2014-01-31 2014-01-29 4 CFN CAREFUSION Corp
Restricted Stock Units
M - Exercise -126.677 0 -100,00
2014-01-31 2014-01-29 4 CFN CAREFUSION Corp
Common Stock
F - Taxes -62.398 187.152 -25,00 39,92 -2.490.928 7.471.108
2014-01-31 2014-01-29 4 CFN CAREFUSION Corp
Common Stock
M - Exercise 126.677 249.550 103,10
2014-01-10 2014-01-09 4 CFN CAREFUSION Corp
Common Stock
S - Sale X -25.000 122.873 -16,91 41,05 -1.026.250 5.043.937
2013-12-02 2013-12-02 4 CFN CAREFUSION Corp
Common Stock
S - Sale X -22.883 147.873 -13,40 40,10 -917.608 5.929.707
2013-12-02 2013-11-29 4 CFN CAREFUSION Corp
Common Stock
S - Sale X -2.117 170.756 -1,22 40,00 -84.680 6.830.240
2013-08-19 2013-08-15 4 CFN CAREFUSION Corp
Options (right to buy)
A - Award 399.645 399.645
2013-08-19 2013-08-15 4 CFN CAREFUSION Corp
Restricted Stock Units
A - Award 53.912 53.912
2013-08-19 2013-08-15 4 CFN CAREFUSION Corp
Restricted Stock Units
M - Exercise -23.329 46.660 -33,33
2013-08-19 2013-08-15 4 CFN CAREFUSION Corp
Restricted Stock Units
M - Exercise -24.452 24.453 -50,00
2013-08-19 2013-08-15 4 CFN CAREFUSION Corp
Common Stock
F - Taxes -24.913 172.873 -12,60 37,45 -932.992 6.474.094
2013-08-19 2013-08-15 4 CFN CAREFUSION Corp
Common Stock
M - Exercise 47.781 197.786 31,85
2013-05-17 2013-05-15 4 VOLC Volcano Corp
Restricted Stock Units
A - Award 3.711 3.711
2013-05-17 2013-05-15 4 VOLC Volcano Corp
Non-Qualified Stock Option (Right to Buy)
A - Award 10.840 10.840 16,84 182.546 182.546
2013-05-17 2013-05-15 4 VOLC Volcano Corp
Restricted Stock Units
M - Exercise -2.193 0 -100,00
2013-05-17 2013-05-15 4 VOLC Volcano Corp
Common Stock
M - Exercise 2.193 6.027 57,20
2013-01-30 2013-01-29 4 CFN CAREFUSION Corp
Restricted Stock Units
M - Exercise -126.676 126.677 -50,00
2013-01-30 2013-01-29 4 CFN CAREFUSION Corp
Common Stock
F - Taxes -61.392 150.005 -29,04 31,12 -1.910.519 4.668.156
2013-01-30 2013-01-29 4 CFN CAREFUSION Corp
Common Stock
M - Exercise 126.676 211.397 149,52
2012-08-16 2012-08-15 4 CFN CAREFUSION Corp
Options (right to buy)
A - Award 478.392 478.392
2012-08-16 2012-08-15 4 CFN CAREFUSION Corp
Restricted Stock Units
A - Award 69.989 69.989
2012-08-16 2012-08-15 4 CFN CAREFUSION Corp
Restricted Stock Units
M - Exercise -24.452 48.905 -33,33
2012-08-16 2012-08-15 4 CFN CAREFUSION Corp
Common Stock
F - Taxes -11.415 84.721 -11,87 26,69 -304.666 2.261.203
2012-08-16 2012-08-15 4 CFN CAREFUSION Corp
Common Stock
M - Exercise 24.452 96.136 34,11
2012-05-24 2012-05-23 4 VOLC Volcano Corp
Restricted Stock Units
A - Award 2.193 2.193
2012-05-24 2012-05-23 4 VOLC Volcano Corp
Non-Qualified Stock Option (Right to Buy)
A - Award 5.689 5.689
2012-05-02 2012-05-02 4 VOLC Volcano Corp
Restricted Stock Units
M - Exercise -1.698 0 -100,00
2012-05-02 2012-05-02 4 VOLC Volcano Corp
Common Stock
M - Exercise 1.698 3.834 79,49
2012-01-31 2012-01-29 4 CFN CAREFUSION Corp
Restricted Stock Units
M - Exercise -126.676 253.353 -33,33
2012-01-31 2012-01-29 4 CFN CAREFUSION Corp
Common Stock
F - Taxes -54.992 71.684 -43,41 23,90 -1.314.309 1.713.248
2012-01-31 2012-01-29 4 CFN CAREFUSION Corp
Common Stock
M - Exercise 126.676 126.676
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)